Landmark Bio

Landmark Bio is a cell and gene therapy manufacturing company that develops innovative technologies, products, and services to bridge the gap from bench to patient. They provide end-to-end support—process development, scale-up and GMP manufacturing, analytical testing, and regulatory-ready workflows—to translate research into clinical‑grade therapies. Focused on enabling academic groups and biotech partners, Landmark Bio offers scalable, compliant solutions and partnership models to accelerate commercialization and bring therapies to patients.